HealthBeacon plc (NZ2.F)
- Previous Close
1.3700 - Open
1.3700 - Bid --
- Ask --
- Day's Range
1.3700 - 1.3700 - 52 Week Range
0.8000 - 1.8100 - Volume
500 - Avg. Volume
0 - Market Cap (intraday)
23.139M - Beta (5Y Monthly) -0.26
- PE Ratio (TTM)
-- - EPS (TTM)
-0.7900 - Earnings Date --
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
--
HealthBeacon plc, a digital therapeutics company, develops products for managing injectable medications for patients in the home in Europe, the United States, and Ireland. Its injection care management system tracks adherence and persistence with medication schedules through the provision of medication management reminders, safe and sustainable sharps disposal devices, educational tools, and artificial intelligence driven data analytics. The company provides HB Wave that notifies the patient and clinician when prescription refills are required and records visual images of pill containers to measure levels of medication adherence; HB Smart Scale which enables patients to add weight monitoring to injection care management system; and Global Patient Safety Platform, a proprietary software platform that help clinicians to prescribe medication to patients. It also sells and leases medical adherence technology devices, injection care management systems, and software risk management platforms. The company was incorporated in 2013 and is headquartered in Dublin, Ireland. As of February 5, 2024, HealthBeacon plc operates as a subsidiary of Hamilton Beach Health.
www.healthbeacon.com70
Full Time Employees
December 31
Fiscal Year Ends
Sector
Industry
Recent News: NZ2.F
Performance Overview: NZ2.F
Trailing total returns as of 4/26/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: NZ2.F
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: NZ2.F
Valuation Measures
Market Cap
1.18M
Enterprise Value
-18.62M
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
10.28
Price/Book (mrq)
1.32
Enterprise Value/Revenue
-8.28
Enterprise Value/EBITDA
1.57
Financial Highlights
Profitability and Income Statement
Profit Margin
0.00%
Return on Assets (ttm)
-39.26%
Return on Equity (ttm)
-80.77%
Revenue (ttm)
2.24M
Net Income Avi to Common (ttm)
-14.11M
Diluted EPS (ttm)
-0.7900
Balance Sheet and Cash Flow
Total Cash (mrq)
1.93M
Total Debt/Equity (mrq)
7.09%
Levered Free Cash Flow (ttm)
-11.76M
Company Insights: NZ2.F
NZ2.F does not have Company Insights